Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: September 2015
-
How to Manage Intellectual Property and Patent Law By Ralf Boscheck* — International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people around the world. The core of the problem: growing global concern about how to ensure affordable access to medicine without damaging the initiatives…
-
By Kevin E. Noonan — Earlier this summer, in Ariosa Diagnostics, Inc. v. Sequenom, Inc., the Federal Circuit affirmed a decision by the District Court for the Northern District of California granting summary judgment of invalidity of the asserted claims of U.S. Patent No. 6,258,540 (see "Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015)"). Last…
-
By Donald Zuhn — Earlier this summer, in Ariosa Diagnostics, Inc. v. Sequenom, Inc., the Federal Circuit affirmed a decision by the District Court for the Northern District of California granting summary judgment of invalidity of the asserted claims of U.S. Patent No. 6,258,540 (see "Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015)"). Last month,…
-
By Leslie Fischer* — Recently, I had the privilege of speaking at the annual meeting of the American Society of Pharmacognosy in Colorado. Members of this scientific association are dedicated to identifying and isolating natural products from various sources, and finding use for these isolated compositions as medicines, cosmetics, food additives, etc. I don't imagine…
-
The Intellectual Property Law Association of Chicago (IPLAC) Paralegal Committee and International Patents Committee will be offering a seminar on "Foreign Patent Filings and PCT National & Regional Phase Entries" on October 15, 2015 from 8:30 to 9:30 am (Central) at The Standard Club in Chicago, IL. Mark W. Croll, Senior Advisor, Valipat S.A. will provide…
-
Strafford will be offering a webinar/teleconference entitled "Hedge Fund IPR Challenges to Pharma Patents: Latest Developments and Strategies to Strengthen Patents — Lessons From PTAB Denial of Acorda Therapeutics IPR, Celgene's Sanctions Motion, and More" on October 12, 2015 from 1:00 to 2:30 pm (EDT). Rekha Bansal, Sr. Director of IP, Principia Biopharma; Thomas L.…
-
Practising Law Institute (PLI) will be holding five live sessions of its Patent Litigation 2015 seminar this fall in Chicago (October 8-9) and New York (November 16-17). In addition, Groupcasts will be held in Pittsburgh, New Brunswick, NJ, Mechanicsburg, PA, Philadelphia, Columbus, OH, and Cleveland on November 16-17. Each session of the Patent Litigation 2015…
-
By Michael Borella — As the fallout from the Supreme Court's Alice Corp. v. CLS Bank Int'l case makes its way through the federal courts and the U.S. Patent and Trademark Office (USPTO), applicants and patentees continue to struggle with the implications of the decision. Alice provided a two-part test for patent-eligibility under 35 U.S.C.…
-
By Kevin E. Noonan — Earlier this summer, in Ariosa Diagnostics, Inc. v. Sequenom, Inc., the Federal Circuit affirmed a decision by the District Court for the Northern District of California granting summary judgment of invalidity of the asserted claims of U.S. Patent No. 6,258,540 (see "Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015)"). Last…
-
By Kevin E. Noonan — Earlier this summer, in Ariosa Diagnostics, Inc. v. Sequenom, Inc., the Federal Circuit affirmed a decision by the District Court for the Northern District of California granting summary judgment of invalidity of the asserted claims of U.S. Patent No. 6,258,540 (see "Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015)"). Last…
Patent Docs 